Who is sponsoring NCT03235830?

NCT03235830 is sponsored by St. Louis University.

What drugs are being tested in NCT03235830?

Interventions in NCT03235830: Enhanced Standard of Care (ESoC) + Text, Enhanced Standard of Care (ESoC).

What condition does NCT03235830 study?

NCT03235830 studies Text Messaging.

Is NCT03235830 still recruiting?

NCT03235830 is currently completed. Last updated 2 August 2017.

Last reviewed 2017-08-02 · How we verify

NCT03235830

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Text Messaging in Healthcare Utilization

Completed NA Last updated 2 August 2017

What this trial tests

NA trial testing Enhanced Standard of Care (ESoC) + Text in Text Messaging in 231 participants. Completed in 5 August 2016.

Timeline

28 January 2015

Primary endpoint
5 August 2016

5 August 2016

Quick facts

Lead sponsor	St. Louis University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	health services research
Enrollment	231
Start date	28 January 2015
Primary completion	5 August 2016
Estimated completion	5 August 2016

Drugs / interventions tested

Enhanced Standard of Care (ESoC) + Text
Enhanced Standard of Care (ESoC)

Conditions studied

Text Messaging — all drugs for Text Messaging →

Sponsor

St. Louis University

Who can join

Adults 15 to 65, any sex, with Text Messaging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The overall goal is to assess the feasibility and effectiveness of using text messages as an educational tool in order to improve health care utilization among the parents and caregivers of newborns; in particular, the investigators seek to understand how educational text messages counteract the effects of low health literacy as it relates to non-urgent visits to the emergency department.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Text Messaging

Currently open trials in the same condition.

NCT06318975 — Text-Based Messaging Strategies for Preventing Subsequent Problematic Alcohol Use · NA · recruiting

Other St. Louis University trials

Trials by the same sponsor.

NCT07024940 — Short-term Effects of Caffeine and a Multi-ingredient Pre-workout on Exercise Performance · NA · recruiting
NCT06859528 — Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease · NA · recruiting
NCT04158037 — Don't Go There: A Geospatial mHealth App for Gambling Disorder · NA · withdrawn
NCT05406310 — Clinical Outcomes of Persistent Atrial Fibrillation Ablation Using Ablation Index-guided Radiofrequency Catheter Ablatio · withdrawn
NCT05854836 — Preconception Intervention for Incarcerated Women With Substance Use · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03235830 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St. Louis University
Last refreshed: 2 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03235830.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing